Canopy Growth Expands German Medical Cannabis Portfolio with Tweed Brand Launch

Key Insights

• Canopy Growth has introduced its established Tweed brand to the German medical cannabis market, launching four new EU-cultivated strains through a partnership with Portuguese cultivator Gro-Vida.
• The expansion includes high-THC genetics with sativa-dominant Jack Herer, indica-prominent Balanced Caramel and Wappa, and hybrid Gelato 33 strains, following December's Glitter Bomb launch with Cansativa.
• This strategic move strengthens Canopy Growth's position in the German medical cannabis sector by ensuring consistent supply through EU-GMP facilities and partnerships with European cultivators.

Canopy Growth Corporation has marked a significant expansion in the European medical cannabis sector with the official launch of its Tweed brand in Germany, introducing four new cannabis strains cultivated within the European Union through a strategic partnership with Portuguese cultivator Gro-Vida S.A.

The expansion brings a diverse range of medical cannabis genetics to German patients, featuring carefully selected strains to address various therapeutic needs. The new portfolio includes Jack Herer, a sativa-dominant variety; two indica-prominent options, Balanced Caramel and Wappa; and Gelato 33, a balanced hybrid strain. This launch follows the successful December 2024 introduction of Tweed's Glitter Bomb, an indica-dominant high-THC strain, through collaboration with German-based Cansativa GmbH.

Strategic Market Position and Supply Chain

"As a leader in medical cannabis, Canopy Growth is expanding its German product lineup with the launch of the Tweed brand as well as new genetics to meet the growing needs of patients and healthcare practitioners," stated Luc Mongeau, CEO of Canopy Growth. The company's approach combines EU-based cultivation partnerships with supply from their EU-GMP certified Canadian facility, ensuring reliable product availability for German healthcare providers and patients.

Brand Heritage and European Expansion

Tweed, established in Canada over ten years ago, brings significant experience from both medical and adult-use markets globally. The brand's entry into Germany represents a strategic enhancement of Canopy Growth's European presence, particularly focusing on meeting the increasing demand for high-THC genetics in the medical sector.

Supply Chain Integration

The company's multi-faceted supply strategy involves:

• Partnership with Portuguese cultivator Gro-Vida for EU-based production
• Collaboration with German distributor Cansativa GmbH
• Continued supply from Canopy's EU-GMP certified Canadian facility

This integrated approach aims to ensure consistent product availability and maintain high quality standards across the German medical cannabis market, enabling healthcare practitioners to confidently prescribe Tweed products to their patients.